Medical Tourism Market (2025 - 2030)

Medical Tourism Market Summary

The total medical tourism market size was estimated at USD 31.09 billion in 2024 and is projected to reach USD 87.33 billion by 2030, growing at a CAGR of 18.47% from 2025 to 2030. Major market drivers include cost savings and extra benefits to visitors, such as cutting-edge technologies, enhanced healthcare, sophisticated equipment, breakthrough medicines, superior hospitality, and personalized care.

During the forecast period, the market is projected to advance at a breakneck pace. The high cost of health services in home countries is the primary factor propelling the market growth. In addition, the industry is being driven by rising demand for procedures that are not covered by insurance, such as gender reassignment surgeries, reproductive therapy, dental reconstruction, and aesthetic surgery.

In developing countries such as Thailand and Malaysia, a high-quality treatment can be availed at a lower cost, than in developed countries. Even though the cost of treatments in developing countries is minimal, the quality of the procedure is not compromised due to the availability of resources at relatively lower costs. This factor results in the influx of people to avail of health services in these countries. For instance, an angioplasty procedure costs around USD 55,000 to USD 57,000 for an individual in the U.S., compared to around USD 2,500 to USD 3,500 in Malaysia. People travel for treatment from America and Europe to Singapore, Malaysia, India, and Thailand, saving between 55% and 70% on medical costs.

In addition, emerging countries are known to have renowned surgeons, which is attracting millions of patients per year for various treatments. The price of medical treatments in Malaysia is 30% to 40% lower than in countries such as the U.S., UK, and other European economies. A large population of foreigners seeks surgeries such as facial aesthetics procedures, dental implants, breast implants, facelifts, and liposuction in these countries. Improvements in healthcare infrastructure and the availability of high-quality healthcare services at affordable prices will drive global market growth. Moreover, the increasing number of tourists across the globe will foster market growth.

Furthermore, delaying necessary treatments might worsen pre-existing conditions, and the risks associated with delaying various surgeries can lead to other complications. For instance, delaying hip replacement surgery can lead to deterioration of the hip joint, limited mobility, and an increase in pain. In addition, the possibility of undergoing minimally invasive surgery, such as hip resurfacing, would no longer be an option for the patient.

Similarly, delaying root canal treatment can lead to the destruction of the tooth, resulting in tooth loss. For instance, in developed countries such as the UK and Canada, there is at least a 4-week wait between the time a patient makes an appointment and the time he/she can see the physician. Canada has the highest percentage of patients (36%) who have to wait 6 days or more for an appointment with a doctor. In the UK, waiting lists for non-essential surgeries, such as knee reconstructions, are up to 18 months, while in Australia and Canada, they can take up to 2 years.

The COVID-19 pandemic had a massive impact on the market, especially in the first half of 2020. The primary reasons for this drop were the imposition of travel restrictions and the global suspension of elective procedures. According to the Thailand Ministry of Tourism and Sports, overall tourist arrivals fell to 6.7 million in 2020, down from 39.9 million in 2019, an 83.2% fall. Similarly, as per the Malaysia Tourism Promotion Board (MTPB), the number of tourists declined by 83.4% in 2020 to 4.33 million. The opening of borders in 2022 and vaccination drives may positively impact the market. The outlook for 2022 appears to be bright. The domestic tourism industry is projected to regain 70% of its pre-pandemic level by 2022, and the number of visits made in China is projected to increase by 16% to 3.98 billion from 2021 onwards. In 2022, the number of inbound and outgoing tourists is projected to increase by 20% annually, recovering 20% of the 2019 level. However, the continuation of “Zero-COVID” policy and lockdowns by the Chinese government might hamper the medical tourism industry in the country.

Market Concentration & Characteristics

The chart below illustrates the relationship between industry concentration, industry characteristics, and industry participants. The x-axis represents the level of industry concentration, ranging from low to high. The y-axis represents various industry characteristics, including the impact of regulations, degree of innovation, industry competition, regional expansion, and level of partnerships & collaboration activities. The market is fragmented, with the presence of many local providers in the market. Furthermore, the degree of innovation is high, and the level of M&A activities is moderate to high. The impact of regulations on the market is high, and service expansion is also high, while regional expansion is moderate.

The degree of innovation is high in the market. The integration of technologies such as telemedicine, artificial intelligence (AI), and data analytics is revolutionizing patient care. These innovations enhance treatment options, improve patient outcomes, and streamline processes for medical tourists. The rise of digital health platforms allows patients to access services like online consultations, appointment scheduling, and health records management from anywhere in the world. For instance, Egypt's government is launching an online health tourism platform to facilitate medical travel bookings.

The industry is expected to continue expanding rapidly, driven by factors such as rising disposable incomes, increased healthcare needs, and technological advancements. The anticipated growth will lead to further M&A activities as companies seek to enhance their service offerings and market presence. For instance, in September 2024, EaseMyTrip.com, a prominent online travel technology platform in India, announced its strategic entry into the growing medical tourism sector by acquiring a 49% equity stake in Pflege Home Healthcare and 30% in Rollins International. These acquisitions are part of EaseMyTrip's broader mission to provide comprehensive travel solutions that integrate wellness and healthcare services into its offerings. This move aligns with the increasing demand for accessible and quality healthcare services among travelers seeking medical treatments and wellness options abroad.

Many governments recognize the economic potential of medical tourism and offer incentives such as tax breaks, financial grants, and streamlined visa processes for medical tourists. These measures not only attract international patients but also encourage healthcare organizations to align their marketing strategies with governmental initiatives, enhancing their competitiveness in the global market. For instance, in India, there is a significant presence of accredited hospitals that meet international standards; however, the absence of comprehensive regulations leaves the sector vulnerable to unregulated practices.

High treatment costs in developed nations are prompting patients to seek more affordable options abroad. Countries such as India, Thailand, and Malaysia offer significant savings on procedures without compromising quality. Major healthcare institutions in countries such as India are expanding their offerings to include comprehensive care packages that cover everything from visa assistance and airport transfers to accommodation and language interpretation services. This approach ensures a seamless experience for international patients.

The affordability of medical procedures in Asia-Pacific countries attracts patients from developed nations where healthcare costs are high. For instance, surgeries that may not be covered by insurance in the U.S. are often available at lower prices abroad. Medical treatments in countries like Thailand, Malaysia, and India are often significantly cheaper—up to 90% less expensive than in Western countries.

Treatment Type Insights

Based on treatment type, the cosmetic segment accounted for the largest revenue share of 24.13% in 2024. Various factors, such as growing patient awareness, increasing demand for anti-aging treatments, and the high cost of cosmetic implants in developed countries, are propelling the market growth. Growing awareness of personal care has significantly increased the demand for cosmetic procedures, including body fat reduction and acne treatments. Common surgeries performed in this context include liposuction, abdominoplasty, breast augmentation, and gluteal augmentation. According to data from the International Society of Aesthetic Plastic Surgery, there was an overall decrease in cosmetic procedures performed by plastic surgeons in 2022. Approximately 33.7 million surgical and non-surgical procedures were carried out globally that year, a rise from about 30.3 million in 2021.

On the other hand, the infertility segment is anticipated to grow at the fastest growth rate over the forecast period. Global trade in health commodities and services is witnessing lucrative growth owing to an increase in production inputs and a rise in international movement of capital. The scenario of international trade in health services is witnessing a paradigm shift owing to the emergence of technological advancements in medicine and communication, thus boosting the international mobility of medical tourists across borders. Furthermore, developing countries, such as India, Thailand, Turkey, and Singapore, are offering subsidized healthcare plans and other favorable care policies, promoting medical tourism.

Service Provider Insights

Based on the service provider, the private segment accounted for the largest revenue share of 54.47% in 2024 and is expected to have the fastest growth rate during the forecast period. The rapid increase in healthcare expenses coupled with a large number of uninsured or underinsured individuals is encouraging medical tourists to avail affordable healthcare services and treatments in developing nations. However, medical tourism faces several challenges in the form of endemic tropical diseases, communication barriers, organ trafficking, and unregulated hospitals. Healthcare providers play a vital role in mitigating these risks by educating and spreading awareness among medical tourists. Healthcare providers are influencing the decision-making of medical tourists by accrediting their practices.

The public segment is projected to have a substantial growth rate during the forecast period. Healthcare globalization and an increase in patient mobility across borders are driving the medical tourism industry. The growth is further accelerated by incorporating advanced technologies, such as telemedicine and e-health, thus, improving accessibility to medical care and treatments in foreign countries. In addition, easy access to transportation facilities, state-of-the-art hospitality & accommodation, and improved communication channels are boosting medical tourism.

Country Insights

Thailand dominated the market in 2024 with a share of 24.40%. Thailand is a key medical tourism destination and is highly popular among foreign travelers. Every year, millions of medical tourists visit Thailand owing to low costs and good quality medical services. Significantly lower treatment costs in comparison to developed economies are a key driver for its growing number of inbound medical tourists. For instance, a hip replacement procedure at Bumrungrad International Hospital in Bangkok costs USD 18,151.37 on average, which is around half the price in the U.S.

The popularity of Mexico as a destination for health tourists from North America has increased in recent years. The fact that prices are lower south of the U.S. border is Mexico's strongest selling factor for individuals willing to travel for medical treatment. This is supported by the data on medical tourism in Mexico, which demonstrates that the savings for a variety of procedures can be substantial. Even something as simple and commonplace as dental care can be up to 70% cheaper in Mexico than in the U.S., while cosmetic surgery can be up to 75% cheaper. Numerous American people and families discover that healthcare costs place a substantial financial strain on their budgets, which makes a trip to Mexico all the more attractive from this perspective.

India medical tourism market is developing as a popular medical center for patients. The healthcare system in India combines traditional and modern medical practices, making it unique from other countries. Further, India's central government has launched various health and social schemes to promote health and wellness tourism in Jammu & Kashmir. The government is developing the infrastructure of the AYUSH Department and has also launched a promotional film highlighting the use of AYUSH in the treatment of diseases. Prime Minister Modi also recently announced plans to launch an AYUSH mark. A sign to give credibility to AYUSH products in India and to promote the Indian medical tourism sector. Additionally, other medical services and facilities are supported by the World Health Organization (WHO) and the United States Food and Drug Administration (US FDA).

Key Medical Tourism Company Insights

These companies use a variety of methods to enhance their market position, including the development of new products and services employing cutting-edge technology, collaborations with other companies, outlet expansion, and corporate investments.

Recent Developments

• In January 2024, Ferns N Petals launched a medical tourism venture named MediJourney, which will provide a comprehensive range of healthcare services across over 30 treatment segments, including cardiology and oncology. This initiative aims to streamline medical travel processes and enhance patient care

• In January 2024, JCB International Indonesia and Sunway Healthcare Group signed a Memorandum of Understanding (MoU) aimed at promoting medical tourism to Malaysia. As part of this agreement, SMC, one of Malaysia's largest private quaternary hospitals located in Sunway City, Kuala Lumpur, will provide preferential wellness packages and additional value-added services specifically tailored for JCB card members. SMC features 28 medical centers, approximately 700 beds, around 500 consultation suites, and a team of over 300 specialists across 60 medical specialties.

• In October 2022, Fortis Healthcare opened a 200-bed multispecialty hospital in Greater Noida. Fortis Healthcare's newest facility is in close proximity to Jewar's new airport, which is expected to increase the number of patients seeking cross-border care services.

Medical Tourism Market